Tag: drugmaker
Browse our exclusive articles!
Alembic Pharma shares gain after drugmaker gets USFDA approval for cancer treatment drug
Alembic Pharmaceuticals Ltd. on Thursday, April 16, said it has received final approval from the US Food and Drug Administration (USFDA) for its generic...
JPMorgan downgrades this drugmaker, cuts price target by 19% citing growth challenges
Shares of Abbott India Ltd. gained on Wednesday, April 15, even as brokerage firm JPMorgan reduced its rating and cut its target price by...
Share Buyback: A ₹1,100 crore drugmaker will be repurchasing its shares for the first time
Shares of Jagsonpal Pharmaceutical Ltd. are in focus on Tuesday, March 10, after the company said its board of directors is looking at considering...
Cipla shares in focus after drugmaker temporarily pauses production of a key drug
Shares of drugmaker Cipla Ltd. will be in focus on Friday, January 16, after the company said in an exchange filing that it is...
Drugmaker Hindustan Laboratories files IPO papers with Sebi to fund working capital
Generic drug maker Hindustan Laboratories has filed preliminary papers with capital markets regulator SEBI to raise funds through an initial public offering (IPO) to...
